ARCHIVES

Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited

This article is from The Cancer Letter archive.

Vol. 02 No. 22 | May 28, 1976

Download PDF Visit The Full Archive

Related Articles

Survey Shows That One-Third Of Patients Are Undertreated

April 27, 2012

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

June 21, 2002

Other News: ESAs Fail To Reduce Blood Transfusions, SEER Data Show

November 20, 2009

At AAAS Meeting, David Baltimore Comments on Bush Administration Science Policy.

March 3, 2006

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

Surveillance Colonoscopy Cost-Effective For High-Risk

July 30, 2010